Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Kimberly-Clark logoKimberly-Clark KMB

Kimberly-Clark said its net sales for Q1 2024 were $5.1 billion, down 1% from a year earlier, while organic sales rose 6%. The company attributed 5% of the decline to currency translation and 1% to the divestiture of its Brazil tissue and K-C Professional business.

8-KResults of Operations and Financial ConditionFiled Period of report Summary published (UTC)

Key points

AI summary
  1. Kimberly-Clark said its net sales for Q1 2024 were $5.1 billion, down 1% from a year earlier, while organic sales rose 6%. The company attributed 5% of the decline to currency translation and 1% to the divestiture of its Brazil tissue and K-C Professional business.

  2. The company said its gross margin for Q1 was 37.1%, up 390 basis points from a year earlier. Diluted earnings per share were $1.91 and adjusted earnings per share were $2.01, up 20% from the prior year, and included a $0.21 year-on-year headwind from currency translation.

  3. Kimberly-Clark said its operating profit for Q1 was $853 million, compared with $787 million a year earlier, and included $45 million in costs related to its transformation initiative. It said adjusted operating profit was $898 million, up 14% from the prior year.

  4. Kimberly-Clark said year-to-date cash provided by operations was $438 million, compared with $613 million a year earlier, mainly reflecting timing differences that affected quarter-end accounts receivable levels. The company also set its 2024 organic net sales outlook at mid-single-digit growth, up from its previous expectation of low- to mid-single-digit growth.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Q1 Net Sales $5.1 billion, Organic Sales Up 6%

Kimberly-Clark said its net sales for Q1 2024 were $5.1 billion, down 1% from a year earlier, while organic sales rose 6%. The company attributed 5% of the decline to currency translation and 1% to the divestiture of its Brazil tissue and K-C Professional business.

Source · Based on the filing body and exhibits

Gross Margin 37.1%, Adjusted EPS $2.01

The company said its gross margin for Q1 was 37.1%, up 390 basis points from a year earlier. Diluted earnings per share were $1.91 and adjusted earnings per share were $2.01, up 20% from the prior year, and included a $0.21 year-on-year headwind from currency translation.

Source · Based on the filing body and exhibits

Operating Profit $853 million, Transformation Costs $45 million

Kimberly-Clark said its operating profit for Q1 was $853 million, compared with $787 million a year earlier, and included $45 million in costs related to its transformation initiative. It said adjusted operating profit was $898 million, up 14% from the prior year.

Source · Based on the filing body and exhibits

Operating Cash Flow $438 million, 2024 Organic Sales Outlook

Kimberly-Clark said year-to-date cash provided by operations was $438 million, compared with $613 million a year earlier, mainly reflecting timing differences that affected quarter-end accounts receivable levels. The company also set its 2024 organic net sales outlook at mid-single-digit growth, up from its previous expectation of low- to mid-single-digit growth.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.